Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 669	$ 2,002
Accounts receivable, net	13	69
Inventory, net	306	319
Prepaid expenses and other current assets	273	249
Total current assets	1,261	2,639
Property and equipment, net	118	119
Deferred offering costs	170	49
Licensed technology	2,226
Other assets	2
Total assets	3,777	2,807
Current liabilities
Accounts payable	438	125
Other accrued expenses	303	147
Total current liabilities	741	272
Total liabilities	741	272
Commitments and contingencies (Note 7)
Stockholders' equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 491 shares issued and outstanding at March 31, 2025 and no shares issued and outstanding at December 31, 2024
Common stock, $0.0001 par value, 200,000,000 shares authorized; 705,641 and 556,902 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively	1	1
Additional paid in capital	48,078	46,075
Accumulated deficit	(45,043)	(43,541)
Total stockholders' equity	3,036	2,535
Total liabilities and stockholders' equity	$ 3,777	$ 2,807